RT Journal Article
SR Electronic
T1 The SHOW COVID-19 cohort: methods and rationale for examining the statewide impact of COVID-19 on the social determinants of health
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.17.23297146
DO 10.1101/2023.10.17.23297146
A1 Schultz, Amy A.
A1 Nelson-Bakkum, Erin
A1 Nikodemova, Maria
A1 Luongo, Sarah
A1 Barnet, Jodi H
A1 Walsh, Matthew C.
A1 Bersch, Andrew
A1 Cadmus-Bertram, Lisa
A1 Engelman, Corinne D.
A1 Lubsen, Julia
A1 Peppard, Paul
A1 Sethi, Ajay
A1 Malecki, Kristen MC
YR 2023
UL http://medrxiv.org/content/early/2023/10/18/2023.10.17.23297146.abstract
AB Background National and large city mortality and morbidity data emerged during the early years of the COVID-19 pandemic, yet statewide data to assess the impact COVID-19 had across urban and rural landscapes on subpopulations was lacking. The SHOW COVID-19 cohort was established to provide descriptive and longitudinal data to examine the influence the social determinants of health had on COVID-19 related outcomes.Methods Participants were recruited from the 5,742 adults in the Survey of the Health of Wisconsin (SHOW) cohort who were all residents of Wisconsin, United States when they joined the cohort between 2008-2019. Online surveys were administered at three timepoints during 2020-2021. Survey topics included COVID-19 exposure, testing and vaccination, COVID-19 impact on economic wellbeing, healthcare access, mental and emotional health, caregiving, diet, lifestyle behaviors, social cohesion, and resilience.Results A total of 2,304 adults completed at least one COVID-19 online survey, with n=1,090 completing all three survey timepoints. Non-Whites were 2-3 times more likely to report having had COVID-19 compared to Whites, females were more likely than males to experience disruptions in their employment, and those with children in the home were more likely to report moderate to high levels of stress compared to adults without children.Conclusion Longitudinal, statewide cohorts are important for investigating how the social determinants of health affect people’s lives, health, and well-being during the first years of a pandemic and offer insight into future pandemic preparation. The data are available for researchers and cohort is active for continued and future follow-up.Key MessagesMortality and morbidity data emerged during the early years of the COVID-19 pandemic at the national scale and in large cities, yet comprehensive social, cultural, and economic population-level data at the state level was lacking for identifying sub-population trends.COVID-19 disrupted lives and affected people differently based on socio-economic status, demographics, family dynamics, geography, health status, and employment.SHOW COVID-19 cohort is a unique non-clinical, non-hospital-based sample with pre-COVID-19 baseline survey data and biospecimen and three waves of COVID-19 data and specimen available to examine effects of COVID-19 on the social determinants of health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Wisconsin Partnership Program (WPP) PERC Award [233 PRJ 25DJ and WPP4444]. WPP supports efforts to improve the health of the people of Wisconsin by supporting partnerships between the University of Wisconsin School of Medicine and Public Health and local, regional, and statewide groups to address the most important health issues in Wisconsin.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the University of Wisconsin-Madison Health Sciences Institutional Review Board [2013-0251-CP132].I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe SHOW COVID-19 study investigators encourage use of COVID-19 Survey data and stored biospecimen for future grants and publications. Limited use data from all waves of the COVID-19 Survey is free and publicly available. Access to complete survey data from COVID-19 Survey, and access to baseline SHOW survey data, are subject to fee-for-service charges available for use via a data request process. The SHOW study investigators encourage collaboration and use of the SHOW COVID-19 cohort, data, and stored biospecimen for future grants and publications. Participants in the SHOW COVID-19 cohort have consented to be contacted for future follow-up studies and SHOW study investigators are available to assist researchers interested in following up the cohort and expanding data collection. For those interested in using the data, or leveraging SHOW COVID-19 cohort or SHOW cohort for ancillary studies, contact the corresponding author or visit the SHOW website: https://show.wisc.edu/